아스트라제네카 백신, "고령층서 강력한 면역반응 확인”
The experimental COVID-19 vaccine being developed by AstraZeneca and the University of Oxford is said to be safe.
Researchers say it triggers a robust immune response for all adults,... including those in the high-risk age groups.
According to the preliminary findings of a peer-reviewed phase two trial published on Thursday,... the study involved 560 healthy adults,... including 240 over the age of 70.
The experimental vaccine produced a similar immune response for adults aged 18 to 55,... and those over 56.
The virus is most dangerous to those with existing health conditions and older adults.
The drugmakers expect the results of its phase three trials to be available in the coming weeks.
